Condition (MeSH)
Polyarteritis Nodosa
ClinicalTrials.gov lists 22 trials for Polyarteritis Nodosa or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
22 of the 22 trials are tagged with Polyarteritis Nodosa itself; the rest are tagged with a narrower condition beneath it.
When did Polyarteritis Nodosa trials start? (17)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2021 | 1 |
| 2019 | 1 |
| 2018 | 1 |
| 2017 | 1 |
| 2016 | 1 |
| 2015 | 2 |
| 2014 | 2 |
| 2013 | 1 |
| 2012 | 1 |
| 2011 | 3 |
Showing 10 of 17 earlier years.
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 22 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Polyarteritis Nodosa trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 4 |
| Phase 3 | 1 |
| Phase 4 | 2 |
| Not applicable | 1 |
| Observational | 14 |
How many Polyarteritis Nodosa trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 5 |
| Completed | 11 |
| Terminated | 1 |
| Unknown status | 5 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Polyarteritis Nodosa trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
Which drugs are being tested for Polyarteritis Nodosa? (3)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Cytoxan | 3 |
| LAMIVUDINE | 1 |
| RITUXIMAB | 1 |
Interventions as named in the registry (12)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Autologous Peripheral Blood Stem Cell Transplantation | 1 |
| Cyclophosphamide, Azathioprine,prednisone,methylprednisolone | 1 |
| Filgrastime (G-CSF) | 1 |
| Azathioprine Pill | 1 |
| corticosteroid and azathioprine | 1 |
Showing 5 of 12 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Polyarteritis Nodosa trials report? (8)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Cellulitis | 1 | 1 |
| Myocardial infarction | 1 | 1 |
| Oral candidiasis | 1 | 1 |
| Polychondritis | 1 | 1 |
| Septic shock | 1 | 1 |
Showing 5 of 8 adverse events.
Which publications cover Polyarteritis Nodosa? (18)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
Showing 5 of 18 publications.
Prevalence (27)
Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.
| Orphanet disease | Type | Class | Geography | Jurisdiction | Mapping relation |
|---|---|---|---|---|---|
| Polyarteritis nodosa | Annual incidence | 1-9 / 1 000 000 | United Kingdom | GB | Unspecified |
| Polyarteritis nodosa | Annual incidence | 1-9 / 1 000 000 | United Kingdom | GB | Exact |
| Polyarteritis nodosa | Annual incidence | 1-9 / 1 000 000 | United Kingdom | GB | Exact |
| Polyarteritis nodosa | Point prevalence | 1-9 / 100 000 | Sweden | Not stated | Exact |
| Polyarteritis nodosa | Annual incidence | 1-9 / 1 000 000 | Australia | Not stated | Exact |
Showing 5 of 27 prevalence observations.
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Polyarteritis nodosa | 767 | Exact | Orphanet Rare Disease Ontology (ORDO) |
| Polyarteritis nodosa | 767 | Exact | Orphadata Science knowledge files, Product 1 |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: sub-conditions in mesh.